Company involving high tech, life sciences and biotech
Austrianova is one business that does services that comprises high tech, life sciences and biotech. It is accompanied with an encapsulation technology with the living cells in bio-inery polymers. In short, we are a life science congregatedcombined company that concentrate in the enclosure of living cells or bacteria in small tablets for guarding which is also recognized as cell encapsulation technology, isolation, storage and transportation. We were first built in the year 2007 and was built in Singapore's best study biotech hub, Biopolis that has global vision in supporting encapsulation services like micro encapsulation.
There is a quick growing area of interest in healthy attention and more specifically, in the matter of neutraceuticals which is the learning and use of probiotic bacteria. Hence, probiotics encapsulation was created. The cell-in-a-box technology was created by Austranova with the goal to defend, isolate, collect and transport living cells. This protective finding can be used for many objectives and can be used to probiotics, cosmetics and agriculture environmental protection and watching as well as forming the basis of a controlling investigation instrument.
In healthcare, this knowledge aids run protected implantation of cells or stem cells such as cell therapy, involving them keep away from the immune system and allowing long term making of therapeutic molecules in patients. In biotechnology, the cell-in-a-box technology shields cells in bioreactors and fermentors and at the same time, it make simpler cleansing of bioproducts manufactured from the cells and it shorten making price too.
A wide gauge cGMP facility for the production of biomedical grade encapsulated cell tools was actually effectively created and right now, Austrianova is in the process of developing this skill in the whole of SE Asia. This means the use of cell-in-a-box was quite a accomplishment for ancreatic cancer! Basically, it is the use of encapsulated cells for cancer cell therapy from genetically modified cells over-expressing a chemo-activating enzyme to permit minor amounts of chemotherapy to be used more productively without the casual enervating side effects. The encapsulated cell are situated, using supraselective catheterisation, into blood vessels that flows to the tumor where they locally change a chemotherapeutic product to its tumor toxic product.
Come to our site for more information: Capsules, Stem Cells, Encapsulation Technology.
